Chia Tai Tianqing Pharmaceutical Group Co., Ltd. drugs

3 results

  • eribulin mesylate

    (Eribulin Mesylate)
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Eribulin mesylate injection is indicated for treating metastatic breast cancer in patients who have received at least two prior chemotherapeutic regimens, including an anthracycline and a taxane. It is also used for unresectable or metastatic liposarcoma in those who have received a prior anthracycline-containing regimen.
    Medication Details

  • fosaprepitant

    (FOSAPREPITANT DIMEGLUMINE)
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Fosaprepitant for injection is indicated for preventing acute and delayed nausea and vomiting in adults and pediatric patients (6 months and older) undergoing highly or moderately emetogenic cancer chemotherapy. It is not studied for treating established nausea and vomiting.
    Medication Details
    Drug Interactions

  • fulvestrant

    (fulvestrant)
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Fulvestrant injection is indicated for the treatment of hormone receptor-positive, HER2-negative advanced breast cancer in postmenopausal women, either as monotherapy for those not previously treated with endocrine therapy or as part of combination therapy with ribociclib, palbociclib, or abemaciclib after disease progression.
    Medication Details
    Drug Interactions